Akoya Biosciences Inc Financial Flexibility Index
Akoya Biosciences Inc financial flexibility index. Akoya Biosciences Inc (AKYA) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of $-7.01 Million (operating CF $-7.21 Million minus capex $204.00K) represents 0% of total liabilities ($118.54 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Akoya Biosciences Inc (2019–2024)
Financial flexibility index of Akoya Biosciences Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Akoya Biosciences Inc across 6 annual periods. Explore how well can Akoya Biosciences Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Akoya Biosciences Inc Financial Flexibility Index by Year (2019–2024)
Akoya Biosciences Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Akoya Biosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Akoya Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.35x | $-41.65 Million | $-44.10 Million | $117.41 Million | ▲ +5.0% |
| 2023 | -0.37x | $-47.25 Million | $-50.90 Million | $126.60 Million | ▲ +5.0% |
| 2022 | -0.39x | $-46.14 Million | $-53.50 Million | $117.45 Million | ▲ +11.8% |
| 2021 | -0.45x | $-30.97 Million | $-36.07 Million | $69.56 Million | ▼ -641.6% |
| 2020 | -0.06x | $-3.55 Million | $-6.84 Million | $59.09 Million | ▲ +34.2% |
| 2019 | -0.09x | $-10.91 Million | $-13.78 Million | $119.57 Million | — |